Bicocca Open Archive

Logo unimib boa
PIAZZA, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.488
AS - Asia 7.014
EU - Europa 6.076
SA - Sud America 926
AF - Africa 160
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 7
Totale 23.715
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.954
SG - Singapore 2.052
IT - Italia 1.744
CN - Cina 1.468
VN - Vietnam 1.451
HK - Hong Kong 798
DE - Germania 687
BR - Brasile 647
RU - Federazione Russa 629
SE - Svezia 523
CA - Canada 445
GB - Regno Unito 428
IE - Irlanda 390
FR - Francia 374
UA - Ucraina 269
JP - Giappone 227
IN - India 196
ES - Italia 169
FI - Finlandia 168
NL - Olanda 167
AT - Austria 131
BD - Bangladesh 129
KR - Corea 124
TR - Turchia 118
AR - Argentina 114
PL - Polonia 67
BE - Belgio 62
CH - Svizzera 59
ID - Indonesia 59
IQ - Iraq 58
DK - Danimarca 54
MX - Messico 54
TW - Taiwan 48
CL - Cile 43
ZA - Sudafrica 43
AU - Australia 40
PK - Pakistan 37
EC - Ecuador 35
SA - Arabia Saudita 33
IR - Iran 32
PH - Filippine 31
GR - Grecia 30
PT - Portogallo 29
VE - Venezuela 29
CO - Colombia 24
MA - Marocco 21
TH - Thailandia 21
UZ - Uzbekistan 21
NO - Norvegia 20
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
KE - Kenya 14
MY - Malesia 14
OM - Oman 14
PY - Paraguay 14
PE - Perù 12
EG - Egitto 11
ET - Etiopia 10
LT - Lituania 10
JO - Giordania 9
LB - Libano 9
SI - Slovenia 9
CI - Costa d'Avorio 8
CR - Costa Rica 8
DZ - Algeria 8
NP - Nepal 8
RE - Reunion 7
RO - Romania 7
AL - Albania 6
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
IL - Israele 6
JM - Giamaica 6
RS - Serbia 6
BG - Bulgaria 5
BH - Bahrain 5
BY - Bielorussia 5
EU - Europa 5
KZ - Kazakistan 5
PA - Panama 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
BB - Barbados 4
HN - Honduras 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
BO - Bolivia 3
HU - Ungheria 3
KW - Kuwait 3
MD - Moldavia 3
MK - Macedonia 3
MT - Malta 3
UG - Uganda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
GH - Ghana 2
IS - Islanda 2
LU - Lussemburgo 2
Totale 23.686
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.468
Singapore 1.241
Hong Kong 772
Ashburn 735
San Jose 584
Milan 543
Woodbridge 490
Ho Chi Minh City 441
Houston 368
Dublin 365
Hanoi 360
Frankfurt am Main 329
Chandler 309
Jacksonville 301
Wilmington 271
New York 259
Santa Clara 247
Toronto 246
Fairfield 228
Dearborn 205
Chicago 184
Los Angeles 182
Beijing 169
Dallas 149
The Dalles 145
Hefei 144
Princeton 144
Seattle 122
Nanjing 115
Vienna 101
Council Bluffs 97
Munich 93
Cambridge 92
Seoul 88
Lauterbourg 86
Rome 82
São Paulo 82
Shanghai 80
Helsinki 77
Boardman 73
Buffalo 72
Moscow 65
Guangzhou 60
Tokyo 60
Lachine 55
Sesto San Giovanni 55
London 48
Orem 48
Da Nang 47
Jakarta 43
Barcelona 40
Lawrence 38
Dong Ket 37
Paris 37
Warsaw 37
Haiphong 36
Madrid 36
Amsterdam 35
Montreal 35
Atlanta 34
Nanchang 34
Rio de Janeiro 34
Baghdad 33
Istanbul 33
Bologna 32
Boston 32
Altamura 31
Brussels 31
Santiago 31
Shenyang 30
Denver 29
Hải Dương 28
Boydton 27
Ha Long 27
Chennai 25
Jinan 25
Nuremberg 25
Andover 23
Bari 23
Florence 23
Hiroshima 23
Hyderabad 23
Naples 23
San Diego 23
Brooklyn 22
Can Tho 22
Hangzhou 22
Tianjin 22
Washington 22
Biên Hòa 21
Changsha 21
Chengdu 21
Falls Church 21
Kent 21
Ninh Bình 21
Ottawa 21
Quận Bình Thạnh 21
Tashkent 21
Buenos Aires 20
Lambeth 19
Totale 13.991
Salva come PNG Salva come JPEG
Nome #
Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization 2.238
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers? 701
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 556
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 511
Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation 509
Feasibility of a standard cognitive assessment in European academic memory clinics 495
Spontaneous Non-Aneurysmal Convexity Subarachnoid Hemorrhage: A Scoping Review of Different Etiologies beyond Cerebral Amyloid Angiopathy 469
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 462
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 435
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 411
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 404
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 365
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 364
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 339
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 334
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 322
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 301
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 296
Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature 295
Cerebral Amyloid Angiopathy-Related Inflammation 292
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 291
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 288
Iatrogenic CAA-ri supported by ARIA-E, raised CSF anti-Aβ autoantibodies and sTREM2 after COVID-19 vaccination 286
Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation 284
Ricerca quantitativa di Epstein-barr virus in campioni di liquor e sangue da pazienti affetti da sclerosi multipla 280
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 277
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 256
Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review 249
Biological markers of vascular damage in Alzheimer’s disease patients 248
Pathogenetic role of anti-AB autoantibodies in Cerebral Amyloid Angiopathy-related inflammation and Alzheimer's disease 247
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 247
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency 244
A challenging diagnosis of reversible “vascular” dementia: Cerebral amyloid angiopathy-related inflammation 244
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy 243
Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology 242
Ubiquitin regulates GGA3-mediated degradation of BACE1 235
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 235
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 235
Anti-Aβ autoantibodies in CAA-ri vs AD patients: different singers for the same ARIA? 232
Abrupt withdrawal of immunosuppressive drugs: a potential trigger for CAA-ri 232
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 226
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 219
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study 218
CSF biomarkers for Amyloid Related Imaging Abnormalities (ARIA) in immunotherapy trials of Alzheimer’s disease and Cerebral Amyloid Angiopathy: report from the iCAß International Network 216
Metodo e kit per la rilevazione di anticorpi 202
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 198
Anti-abeta antibodies in CSF: markers for therapies? 198
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 195
BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus. 194
The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications 194
Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease 194
Author Response: Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study 194
Increased levels of tissue factor pathway inhibitor in cerebrospinal fluid are related to neurodegeneration in alzheimer’s disease patients 191
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 185
Pathogenetic similarities shared by Alzheimer's disease and multiple sclerosis 180
Hemostasis components in cerebral amyloid angiopathy and Alzheimer’s disease 179
Effect of TNF-alpha on platelet glutamate uptake in Stroke patients 176
CSF anti-Aß autoantibodies as novel biomarker for Cerebral Amyloid Angiopathy-related inflammation: implications for amyloid-related imaging abnormalities (ARIA) during passive immunization in Alzheimer’s disease 176
Platelets might mediate the increase of plasma glutamate in acute ischemic stroke: Relevance for early neurological deterioration 174
Autologous anti-Aß antibodies in caa-ri: new biomarker for detection of Amyloid-Related Imaging Abnormalities (ARIA) during Aß-disease modifying therapies for AD 174
Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease 173
Symposium Immunotherapy Trials in CAA and AD: The ARIA paradox in AD and CAA: merely an adverse event or an out of tune proof of immunotherapy effectiveness? 170
Biomarkers in cerebral amyloid angiopathy-related inflammation 169
Analytical Validation of a pre-Industrial Prototype Assay for Anti-Aβ Autoantibody ultrasensitive quantification in patients with CAA-ri and ARIA-E of Alzheimer’s disease Immunotherapy 168
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease 168
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 168
Microbiota-gut-brain axis dysregulation in Alzheimer’s disease and its modulation through probiotic supplementation 167
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 164
A method and a kit for the detection of anti-beta amyloid antibodies 164
Inflammatory CAA and AD Biomarkers International Network 162
Non-vascular leucoencephalic dementia: The case of Cerebral Amyloid Angiopathy related inflammation 161
Neurovascular Manifestations of Iron-Deficient Anemia: Narrative Review and Practical Reflections through a Teaching Case 159
Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy? 159
Pathogenetic Role of Anti- Aß Autoantibodies in CAA-related Inflammation: Implications for Amyloid-modifying Therapies in AD 159
Anti-Aß autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease βiomarkers Collaborative Network (iCAβ) 157
CAA-ri and ARIA: Two Faces of the Same Coin? 154
Natural amyloid-beta oligomers acutely impair the formation of a contextual fear memory in mice 152
Cerebral amyloid angiopathy-related inflammation. report of a case 148
The Venular Side of Cerebral Amyloid Angiopathy: Proof of Concept of a Neglected Issue 147
Cerebrospinal Fluid Anti-Amyloid-Beta; Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation 147
Anti-Amyloid Treatments: A Therapeutic Revolution, Ready for Europe 145
Auto-antibodies to Aß in CSF 145
Vascular damage and neurodegeneration 145
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 143
In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model 140
Why does ARIA‐E appear bright? A quantitative model linking brain tissue composition and T2 FLAIR hyperintensities 137
Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA) 135
Large Collaborative Registries and Real-World Data to Manage Amyloid-Related Imaging Abnormalities 134
Données récentes sur l’Amyloïdose Cérébrale Inflammatoire. 129
Monoclonal antibodies for early Alzheimer disease: a long road to discovery and marketing approval, a short timeline for health systems to organise services 124
Advancing dementia care: a review of Italy's public health response within the WHO Global Action Plan and European strategies 120
Inflammatory CAA mechanisms and biomarkers– lessons for sporadic CAA diagnosis and treatment 115
The inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease Biomarkers International Network (iCAβ) initiative 113
Anti-Aß autoantibodies and endothelial damage during spontaneous Amyloid-Related Imaging Abnormalities (ARIA): report from the inflammatory cerebral amyloid angiopathy and alzheimer's disease biomarkers collaborative network (iCAB) 113
Abstract W MP89: Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 107
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 93
Spontaneous and Drug-Induced Amyloid-Related Imaging Abnormalities: Overlaps, Divergences, and Clinical Implications Across a Continuum Between Alzheimer’s Disease and Cerebral Amyloid Angiopathy 75
Iatrogenic cerebral amyloid angiopathy and cerebral amyloid angiopathy-related inflammation: clinical, radiological and biological findings from a case 59
The Inflammatory Side of Iatrogenic Cerebral Amyloid Angiopathy: Rethinking Therapeutic Opportunities 50
Mechanisms of Dural Involvement in Cerebral Amyloid Angiopathy 42
Totale 24.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.441
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021141 0 0 0 0 0 0 0 0 0 0 0 141
2021/20221.039 96 86 114 97 74 106 33 31 42 76 74 210
2022/20231.727 204 419 146 146 147 232 96 91 172 16 37 21
2023/20241.316 44 67 59 62 180 274 229 82 133 32 39 115
2024/20253.696 164 421 317 135 297 179 277 202 382 463 291 568
2025/202611.386 1.434 862 773 1.136 1.207 791 1.452 747 1.066 943 703 272
Totale 24.565